Literature DB >> 1868461

Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors.

B E Miller1, T Machemer, M Lehotan, G H Heppner.   

Abstract

Paired mixtures of melphalan-sensitive and relatively insensitive tumor cell subpopulation lines, originally derived from the same mammary tumor, were injected s.c. into syngeneic mice. When tumors were palpable, the mice were treated with melphalan at doses shown to be effective against the melphalan-sensitive subpopulations. Sensitivity was assessed by the loss of colony-forming ability of tumor cells harvested 1 to 14 days after treatment. When growing in tumors mixed with melphalan-sensitive line 4TO7 cells, line 66 (less sensitive) appeared much more sensitive than when it was grown alone. Line 66 tumors growing on the opposite sides of mice bearing line 4TO7 tumors were not more sensitive than when grown alone, indicating the lack of a systemic mechanism in the transfer of sensitivity from 4TO7 to 66. Furthermore, line 66 was not more sensitive when mixed with line 168TFAR (another melphalan-sensitive subpopulation) than when alone. The "transfer of sensitivity" from line 4TO7 to line 66 could be reproduced in collagen gel cultures but not in monolayer. Interestingly, line 4TO7, unlike line 168TFAR, is more sensitive to melphalan in collagen culture than in monolayer. This difference in sensitivity does not appear to be influenced by differences in cell density between the two culture systems. In collagen culture, the increased sensitivity of line 66 in the presence of line 4TO7 did not require cell contact and so appeared to act through diffusible factors(s). Collectively, these data suggest that the transfer of sensitivity is not dependent upon host factors or upon drug sensitivity per se but rather upon some mechanism requiring tumor cell-tumor cell interaction between specific subpopulation pairs. In additional studies, pH was ruled out as a factor in the transfer of sensitivity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1868461

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Tumorigenesis: it takes a village.

Authors:  Doris P Tabassum; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2015-07-02       Impact factor: 60.716

Review 2.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Use of tumor lines with selectable markers in assessing the effect on experimental metastases of combination chemotherapy with alkylating agents.

Authors:  B E Miller; L Delmonico; K Vistisen; F R Miller
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

4.  Computer-assisted microscope characterization of BCNU-induced modifications in the collective behavior of 12 human brain cancer cell lines.

Authors:  I Camby; I Salmon; A Danguy; J L Pasteels; R Kiss
Journal:  J Neurooncol       Date:  1996-04       Impact factor: 4.130

5.  Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells.

Authors:  Andre Levchenko; Bipin M Mehta; Xinle Niu; Grace Kang; Liliana Villafania; Denise Way; Dolores Polycarpe; Michel Sadelain; Steven M Larson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

Review 6.  Intra-tumour heterogeneity: a looking glass for cancer?

Authors:  Andriy Marusyk; Vanessa Almendro; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2012-04-19       Impact factor: 60.716

7.  An in vitro co-culture model of esophageal cells identifies ascorbic acid as a modulator of cell competition.

Authors:  Lauren M F Merlo; Rachelle E Kosoff; Kristin L Gardiner; Carlo C Maley
Journal:  BMC Cancer       Date:  2011-10-25       Impact factor: 4.430

Review 8.  The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome.

Authors:  Deborah R Caswell; Charles Swanton
Journal:  BMC Med       Date:  2017-07-18       Impact factor: 8.775

9.  Statistical tests for intra-tumour clonal co-occurrence and exclusivity.

Authors:  Jack Kuipers; Ariane L Moore; Katharina Jahn; Peter Schraml; Feng Wang; Kiyomi Morita; P Andrew Futreal; Koichi Takahashi; Christian Beisel; Holger Moch; Niko Beerenwinkel
Journal:  PLoS Comput Biol       Date:  2021-12-15       Impact factor: 4.475

10.  Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.

Authors:  B E Miller; F R Miller; T Machemer; G H Heppner
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.